NovoCure Ltd — Institutional Ownership
Which tracked institutions hold NVCR, and how they changed the position last quarter. Latest holdings as of Sep 30, 2026. Source: SEC 13-F filings.
24
Funds holding
$455786856
Total value held
Buying
17 added/new · 6 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Blackrock, Inc. | $203217541 | 13413699 | +219934 | +1.67% |
| 2 | Morgan Stanley | $68514216 | 4522389 | -19137 | -0.42% |
| 3 | State Street Corp | $43428172 | 2866546 | +304729 | +11.90% |
| 4 | Wells Fargo & Company/Mn | $39588358 | 2613093 | -508144 | -16.28% |
| 5 | Jpmorgan Chase & Co | $25943489 | 1671082 | +740916 | +79.65% |
| 6 | Northern Trust Corp | $14744011 | 973202 | +89624 | +10.14% |
| 7 | Goldman Sachs Group Inc | $14603350 | 963917 | +218482 | +29.31% |
| 8 | Bank Of America Corp /De/ | $11555269 | 762724 | +592711 | +348.63% |
| 9 | Franklin Resources Inc | $6580554 | 434360 | +145064 | +50.14% |
| 10 | Citigroup Inc | $6295083 | 415517 | +208698 | +100.91% |
| 11 | Ubs Group Ag | $5100067 | 336638 | +336638 | NEW BUY |
| 12 | Bank Of New York Mellon Corp | $4628573 | 305516 | +24045 | +8.54% |
| 13 | Barclays Plc | $3683511 | 243136 | -54280 | -18.25% |
| 14 | Invesco Ltd. | $3232586 | 213372 | +213372 | NEW BUY |
| 15 | Federated Hermes, Inc. | $2265470 | 149536 | +149536 | NEW BUY |
| 16 | Sei Investments Co | $1102460 | 72769 | -41512 | -36.32% |
| 17 | Janus Henderson Group Plc | $490725 | 45000 | +45000 | NEW BUY |
| 18 | Allstate Corp | $284608 | 18786 | +18786 | NEW BUY |
| 19 | Prudential Financial Inc | $267398 | 17650 | +2220 | +14.39% |
| 20 | Royal Bank Of Canada | $218000 | 14348 | +5137 | +55.77% |
| 21 | First Bancorp, Inc /Me/ | $37875 | 2500 | +2500 | NEW BUY |
| 22 | Us Bancorp \De\ | $3121 | 206 | -1127 | -84.55% |
| 23 | Pnc Financial Services Group, Inc. | $1621 | 107 | -689 | -86.56% |
| 24 | Tompkins Financial Corp | $798 | 50 | — | Held |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.